Concourse Financial Group Securities, Inc. Vir Biotechnology, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$6.48 - $12.48 $0 - $0	0 New	0 $0
Q4 2024 Feb 13, 2025	BUY	$6.74 - $10.17 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	BUY	$7.26 - $10.7 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$7.63 - $12.66 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	SELL	$8.6 - $11.9 $17 - $23	-2 Closed	0 $0
Q3 2023 Oct 25, 2023	BUY	$9.14 - $24.62 $18 - $49	2 New	2 $0
Q2 2023 Aug 10, 2023	BUY	$23.2 - $27.29 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$19.96 - $28.22 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$18.26 - $31.1 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$19.08 - $26.7 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	SELL	$21.19 - $40.01 $5,149 - $9,722	-243 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$30.97 - $54.03 $7,525 - $13,129	243 New	243 $10,000
Q3 2021 Nov 09, 2021	BUY	$34.9 - $54.54 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$38.75 - $51.0 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$26.34 - $83.07 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$25.51 - $43.38 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$28.28 - $53.6 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$12.04 - $60.2 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.83 - $15.85 $0 - $0	0 New	0 $0

Others Institutions Holding VIR

# of Institutions

255

Shares Held

92.6M

Call Options Held

257K

Put Options Held

261K

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$82.4 Million
0.99% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$81.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.8M
Shares

$63.3 Million
0.0% of portfolio
State Street Corp Boston, MA

5.73M
Shares

$28.3 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.68M
Shares

$13.3 Million
0.0% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $655M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account